Use of fibrinogen to enhance the antitumor effect of OK-432 - Monden, T; Morimoto, H; Shimano, T; Yagyu, T; Murotani, M; Nagaola, H; Kawasaki, Y; Kobayashi, T (Cancer, 1992)